Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

Both Wegovy and Ozempic are semaglutide – a drug that first entered the US market in 2017 as a diabetes medication. It was ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...

As medications like Ozempic transform the health of millions of Americans, some families are discovering a surprising side ...

The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...